Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma

被引：0
|
作者：
Huiyong Wu
Wei Zhao
Jianbo Zhang
Jianjun Han
Shuguang Liu
机构：
[1] Shandong Tumor Hospital Affiliated to Shandong University,Department of Intervention
[2] Shandong Tumor Hospital Affiliated to Shandong University,Department of Radiotherapy
[3] Shandong Tumor Hospital Affiliated to Shandong University,Department of pathology
[4] Shandong Tumor Hospital Affiliated to Shandong University,Department of Thoracic Oncology Surgery
来源：
BMC Gastroenterology | / 18卷
关键词：
Hepatocellular carcinoma; Hepatic arterioportal shunts; Portal vein tumor embolus; Transarterial chemoembolization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts
    Tesdal, I. Kaare
    Wikstroem, Mats
    Flechtenmacher, Christa
    Filser, Thomas
    Dueber, Christoph
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 29 (05) : 778 - 784
  • [32] OUTCOME OF LOCALIZED HEPATOCELLULAR-CARCINOMA TREATED WITH SEGMENTAL ARTERIOPORTAL CHEMOEMBOLIZATION
    NAKAMURA, H
    OI, H
    HORI, S
    TAKAYASU, Y
    FURUI, S
    SAWADA, S
    KOZUKA, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S69 - S71
  • [33] TACE Combined with Portal Vein Tumor Thrombus 125I I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
    Xia, Wei-Li
    Zhao, Xiao-Hui
    Guo, Yuan
    Hu, Hong-Tao
    Li, Hai-Liang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1689 - 1697
  • [34] Baseline characteristics associated with survival in patients with hepatocellular carcinoma
    Aslanov, Seymur
    Unal, Nalan Gulsen
    Senkaya, Ali
    Celik, Ferit
    Buyruk, Abdullah Murat
    Uysal, Alper
    Akyildiz, Murat
    Turan, Ilker
    Gunsar, Fulya
    Ersoz, Galip
    Karasu, Abdullah Zeki
    Ozutemiz, Ahmet Omer
    Akarca, Ulus Salih
    HEPATOLOGY FORUM, 2022, 3 (01): : 3 - 10
  • [35] Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
    Fei, Zuo
    Lijuan, Yin
    Jing, Zhuang
    Xi, Yang
    Yuefen, Pan
    Shuwen, Han
    HUMAN CELL, 2021, 34 (01) : 177 - 186
  • [36] Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma
    Dohmen, K
    Shigematsu, H
    Irie, K
    Ishibashi, H
    HEPATO-GASTROENTEROLOGY, 2003, 50 (54) : 1872 - 1877
  • [37] Hepatocellular carcinoma in Austria:: aetiological and clinical characteristics at presentation
    Schöniger-Hekele, M
    Müller, C
    Kutilek, M
    Oesterreicher, C
    Ferenci, P
    Gangl, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (08) : 941 - 948
  • [38] Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents
    Xu-Feng Zhang
    Xue-Min Liu
    Tao Wei
    Chang Liu
    Mu-Xing Li
    Zhi-Da Long
    Yi Lv
    Pediatric Surgery International, 2013, 29 : 763 - 770
  • [39] Overexpression of cytoskeleton associated protein 4 in tumor tissues is associated with clinical characteristics and poor prognosis of hepatocellular carcinoma
    Chen, Zhi-Yong
    Wang, Ting
    Zhang, Kun He
    Gan, Xia
    He, Yu Ting
    Chen, Si-Hai
    Wang, Yu-Qi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 189 - 189
  • [40] Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
    Zuo Fei
    Yin Lijuan
    Zhuang Jing
    Yang Xi
    Pan Yuefen
    Han Shuwen
    Human Cell, 2021, 34 : 177 - 186
12345